IGC Pharma : Announces Positive Interim Results for IGC-AD1

IGC Pharma Announces Positive Interim Results for IGC-AD1 in


Reducing Alzheimer's Agitation


- Interim Data: Study Achieves Primary End Point Demonstrating...

Related Keywords

Mansfield , Nunavut , Canada , United States , Americans , American , Ram Mukunda , Janet Vasquez , Rosalyn Christian , Pharma Inc , Drug Administration , Exchange Commission , Announces Positive Interim Results , Statistically Significant Reductions Compared , Agitation Associated , Dementia Due , Cohen Mansfield Agitation Inventory , Specified Interim Results , Illustrative Brexpiprazole Phase , Artificial Intelligence , Looking Statements , Risk Factors , Annual Report , Quarterly Report ,